TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
GPCR

Structure Therapeutics Inc.

Healthcare · Biotechnology

19.80$ -5.3% vs. previous close Closing price · As of: Nov 12, 2026

Statements

Balance Sheet

Structure Therapeutics Inc. (GPCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 26), "Total Assets" came in at 1,334 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GPCR
Line item Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26
482 457 947 933 903 867 816 832 1,584 1,508 1,425 1,334
474 449 938 924 891 850 799 814 1,570 1,491 1,372 1,275
130 98 382 172 170 152 147 103 800 316 273 222
467 436 927 915 884 837 786 799 1,446 1,459 1,343 1,240
29 27 26 36 38 42 44 62 68 61 71 113
25 24 23 33 36 36 39 58 63 57 66 107
1.4 1.6 1.6 1.7 1.7 2.5 2.7 2.8 2.9 2.6 2.6 2.8
4.7 6.5 2.2 8.4 8.0 8.7 9.0 18 14 7.8 11 34
453 430 921 897 865 825 772 770 1,516 1,447 1,354 1,222
-207 -233 -259 -293 -329 -376 -438 -503 -470 -546 -652 -797
46 47 49 57 57 57 58 58 59 72 73 73

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?